Skip to main content
Home/Locations/Licensed Telehealth in Delaware
Licensed Telehealth in Delaware

Online weight loss care,reviewed for Delaware residents.

Semaglutide$169/mo
Tirzepatide$219/mo

GLP-1 weight loss treatment reviewed online by providers licensed in Delaware. Clear monthly pricing, no insurance required, and discreet shipping to your Delaware address if prescribed.

Takes about 5 minutes · Free to start · Secure online intake

No separate medication charge. No insurance involved. Free shipping if prescribed.

Medication included if prescribedNo separate medication chargeNo insurance involvedDiscreet shipping to your doorLicensed provider review

Provider Review

Your provider in Delaware

Delaware residents access care through providers licensed by the Delaware Board of Medical Licensure and Discipline. The online intake is completed at your convenience, and an asynchronous provider review follows. Your health history, BMI, medications, and treatment goals are carefully evaluated.

01

Complete the online health intake from Wilmington, Dover, Newark, or anywhere in Delaware.

02

A Delaware-licensed provider reviews your health information.

03

If medically appropriate, a prescription is issued to a licensed compounding pharmacy.

04

Medication ships discreetly to your Delaware address.

Delaware Telehealth Note

Under Delaware Board of Medical Licensure and Discipline rules, a telehealth treatment relationship cannot be established solely through an online form or questionnaire. Delaware residents are automatically routed to a brief live video or telephonic consultation with a licensed provider following intake checkout to complete the clinical evaluation as required by state law.

WARNING: RISK OF THYROID C-CELL TUMORS

  • In rodents, semaglutide and tirzepatide cause dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. It is unknown whether these medications cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans.
  • Human relevance of the rodent findings has not been determined. There have been no controlled studies establishing a causal relationship between GLP-1 receptor agonists and MTC in humans.

Contraindications

These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Patient Counseling

Counsel patients regarding the potential risk of MTC and inform them of the symptoms of thyroid tumors — including a mass or lump in the neck, difficulty swallowing (dysphagia), shortness of breath (dyspnea), and persistent hoarseness. Routine monitoring of serum calcitonin or thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with these medications.

This boxed warning is the FDA's most stringent warning for prescription drugs. It applies to all GLP-1 receptor agonists including semaglutide and tirzepatide. Discuss any concerns with your Surfbound provider during the intake review.

What to Expect

How it
works.

Here is exactly what happens from the moment a Delaware patient begins the intake to the day the medication arrives.

01

Complete a simple online intake

Answer questions about your health history, goals, and current medications, all from your phone or computer. No waiting rooms, no scheduling hassle. Takes about five minutes.

Delaware residents fill this in from home; nothing is done in person at this stage.

02

A licensed clinician reviews your case

Every submission is reviewed by a licensed medical provider who evaluates your information carefully and determines whether treatment is clinically appropriate for you.

The reviewer holds an active Delaware licence, which is what makes the remote review valid for a Delaware patient.

In most states, no webcam or live call is required. A small number of states require a brief phone or video visit before a prescription can be issued.

03

Prescription issued only if appropriate

If the clinician determines treatment is right for you, a prescription is written. If not, you receive a clear explanation. Treatment is never guaranteed.

Declining is a real outcome for Delaware applicants, not a formality.

04

Medication fulfilled by licensed pharmacy partners

Your prescription is sent to a licensed compounding pharmacy. Surfbound Health connects you with clinicians and pharmacy partners — we are not a pharmacy ourselves.

The pharmacy is licensed and ships into Delaware; Surfbound does not dispense medication and has no Delaware counter.

05

Medication ships discreetly to your door

If prescribed, your medication ships directly to you. Shipping is included in your monthly price. Ongoing clinician support is included throughout your treatment.

Medication reaches your Delaware address in unbranded packaging, with tracking sent on dispatch.

Licensed clinicians

Every review, every time

Licensed U.S. pharmacy partners

Prepared by licensed compounding pharmacies

HIPAA-compliant

Your data stays private

Ongoing support

Included with treatment

Looking for city-level details in Delaware?

Browse our 0 Delaware city pages — including , and more — for provider info, shipping specifics, and local weight loss resources near you.

View Delaware city pages

Provider Access & Process

Preparing for your Delaware review

The clinical steps below belong to this page — the Delaware coverage page lists cities and shipping instead, so the two families do not repeat the same long process article.

Before your review

Having the following ready helps your licensed provider review your information:

  • A current list of your medications and doses
  • Allergies and any prior reactions to medication
  • Your weight history and current height/weight
  • Relevant medical conditions and past surgeries
  • Recent lab results, if you have them on hand

Prescription review

A licensed provider credentialed in Delaware reviews your intake and determines whether treatment is medically appropriate.

A prescription is not guaranteed. If treatment is not appropriate, you receive a clear explanation. If it is, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly.

Switching providers

Already taking a GLP-1? We can match your current dose when clinically appropriate. Sign up and use the doctor-notes field at the end of the form to list your current medication and dose, and whether you want to stay at that dose or discuss increasing it. Your clinician reviews the request and determines the prescription.

Shipping to Delaware

Discreet delivery to your door

Medication ships in discreet, unbranded packaging. Free shipping if prescribed is included with your monthly treatment. Here is what to expect for Delaware deliveries.

Delivery Estimates

Prescriptions for Delaware patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the Mid-Atlantic region, from Wilmington, Dover, Newark to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.

What to Know

Outer packaging for Delaware orders is unbranded, temperature control is added when needed, and tracking is emailed once the pharmacy dispatches.

Common Questions

Telehealth in Delaware

Everything Delaware residents typically want to know before starting their evaluation.

Yes. Licensed medical providers review health intakes and prescribe GLP-1 medication — including compounded semaglutide and tirzepatide — to eligible Delaware residents through Surfbound Health's telehealth platform. A provider licensed in Delaware reviews your health history before determining if treatment is medically appropriate.

No. In most cases, you do not need an in-person visit. The provider review is completed online based on the health intake you submit. A small number of states require a brief live phone or video call before a prescription can be issued. If that applies to Delaware, we will let you know clearly after your intake is submitted.

Yes. Delaware law permits licensed providers to prescribe medication via telemedicine when a proper provider-patient relationship has been established. Surfbound's online health intake and provider review process satisfies this requirement. Providers are licensed by the Delaware medical board.

Compounded semaglutide is $169 per month. Compounded tirzepatide is $219 per month. Both include the provider review, medication (if prescribed), supplies, and discreet shipping to Delaware. No insurance is required. Pricing is transparent — you see the cost before committing.

Prescriptions for Delaware patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the Mid-Atlantic region, from Wilmington, Dover, Newark to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.

No insurance is involved for Delaware residents. Nothing is submitted to a Delaware plan, so a coverage exclusion for weight-loss medication never blocks the provider review.

A licensed provider reviews your health history, current medications, BMI, allergies, and treatment goals. Most reviews are completed within 24 hours on business days. If treatment is medically appropriate, a prescription is sent to a licensed compounding pharmacy, and medication ships to your Delaware address. If treatment is not appropriate, you receive a clear explanation.

Still have questions about Delaware treatment?

Email us at hello@surfbound.co

Provider-Reviewed · Serving Delaware Residents

Ready to start?

Complete the intake in about 5 minutes. A licensed provider reviews your case and gives you a clear answer. Treatment ships discreetly to your Delaware address if prescribed.

High Quality

Licensed pharmacy partners

Zero Friction

Simple online intake

Radical Transparency

Clear pricing before checkout

Takes about 5 minutes · Free to start · Provider reviewed